Published in Probl Tuberk on January 01, 1990
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA (2000) 8.42
Tuberculosis trends in eastern Europe and the former USSR. Tuber Lung Dis (1994) 1.81
[L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis]. Probl Tuberk (1980) 0.87
[Distribution of HLA antigens in patients with tuberculosis]. Ter Arkh (1981) 0.82
Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group. Bull World Health Organ (1998) 0.82
Filtrable forms of mycobacteria tuberculosis. Z Erkr Atmungsorgane (1984) 0.79
[Molecular characteristics of multiresistant clinical strains of Mycobacterium tuberculosis isolated in Russia]. Mol Gen Mikrobiol Virusol (2000) 0.79
[Alcoholism and pulmonary tuberculosis]. Vestn Akad Med Nauk SSSR (1989) 0.77
[Significance of the L transformation and reversion of the causative agent in the epidemiology of tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1984) 0.77
[Model of destructive tuberculosis in guinea pigs]. Biull Eksp Biol Med (1981) 0.77
Effects of chemotherapy on the immunological characteristics of patients with primary destructive pulmonary tuberculosis. Bull World Health Organ (1984) 0.75
[Basic trends in the development in the field of tuberculosis in the USSR]. Probl Tuberk (1977) 0.75
[Diagnosis and treatment of fibrosing alveolitis]. Ter Arkh (1987) 0.75
[Diagnosis of pulmonary hemosiderosis]. Ter Arkh (1978) 0.75
[Levamisole and diucifon immunochemotherapy of chronic destructive pulmonary tuberculosis]. Probl Tuberk (1984) 0.75
[Diagnosis of tuberculosis and other lung diseases with similar clinico-roentgenological signs]. Probl Tuberk (1985) 0.75
[Collective experience with bacteriophage typing and identification of Mycobacterium tuberculosis isolated in the USSR and CSSR]. Probl Tuberk (1987) 0.75
[Rifampicin in the treatment of newly detected destructive pulmonary tuberculosis]. Probl Tuberk (1978) 0.75
[Clinical significance of the diagnostic broncho-alveolar lavage]. Ter Arkh (1983) 0.75
[Classification of sarcoidosis]. Probl Tuberk (1982) 0.75
[Sarcoidosis of the respiratory organs (diagnosis and treatment)]. Klin Med (Mosk) (1983) 0.75
[Clinical picture and diagnosis of rare lung diseases]. Ter Arkh (1979) 0.75
[Clinico-roentgenological diagnosis of lesions affecting the middle lobe of the lung]. Sov Med (1977) 0.75
[Modern concepts of the structure of Mycobacterium tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1982) 0.75
[The etiologic significance of ultrafine forms of the causative agent of tuberculosis in the development of sarcoidosis of the respiratory organs]. Probl Tuberk (1989) 0.75
[X-ray diagnosis of histiocytosis X]. Ter Arkh (1988) 0.75
[Results of a discussion on determining the timely and late detection of a case of tuberculosis]. Probl Tuberk (1981) 0.75
[Exogenous allergic alveolitis]. Sov Med (1982) 0.75
[Characteristics of morphological changes in the lungs of guinea pigs after administration of ultra-small forms of Mycobacteria obtained from patients with tuberculosis]. Probl Tuberk (1986) 0.75
Role of broncho-alveolar lavage in the diagnosis of pulmonary disease. Arch Monaldi Mal Torace (1989) 0.75
[Scientific cooperation of the research phthisiologists of the socialist contries]. Probl Tuberk (1980) 0.75
[Diagnosis of exogenous allergic alveolitis]. Probl Tuberk (1983) 0.75
[Proteolytic and antiproteolytic potential of the sputum in chronic bronchitis patients during exacerbation]. Ter Arkh (1983) 0.75
[Diagnosis of granulomatous lung diseases]. Probl Tuberk (1991) 0.75
[Current identification of early and timely detection of patients with tuberculosis]. Probl Tuberk (1976) 0.75
[Tasks of the research institutes and the Chairs of tuberculosis in various USSR republics regarding the problem of chemotherapy of tuberculosis]. Probl Tuberk (1978) 0.75
[Scientific-technical progress and the practice of phthisiatry]. Probl Tuberk (1986) 0.75
[X-ray semiotics of the morphological and functional changes in chronic bronchitis]. Ter Arkh (1985) 0.75
[Differential diagnosis of intrathoracic adenopathies and pulmonary dissemination of different etiology]. Ter Arkh (1978) 0.75
[Development and improvement of work in antituberculous dispensaries]. Sov Med (1977) 0.75
[Clinical x-ray diagnosis of congenital lung development defects of the disseminated type in adults]. Ter Arkh (1984) 0.75
[Effectiveness of the treatment of experimental destructive pulmonary tuberculosis with antibacterial drugs combined with levamisole and diucifon]. Probl Tuberk (1984) 0.75
[The role of broncho-alveolar lavage in the diagnosis of pulmonary diseases]. Plucne Bolesti (1988) 0.75
[Diagnostic importance of the quantitative determination of the extent of bacteria excretion during the chemotherapy process in chronic destructive pulmonary tuberculosis]. Probl Tuberk (1981) 0.75
[60th anniversary of the founding of the USSR and tasks in the further development of phthisiology and pulmonology]. Probl Tuberk (1982) 0.75
[Opportunities for the evaluation of the secondary reaction of antituberculosis drugs by several indicators, determined in the blood of patients with tuberculosis of the lungs]. Vopr Med Khim (1983) 0.75
[Morphologic and biochemical changes in Mycobacterium tuberculosis during chemotherapy]. Probl Tuberk (1983) 0.75
[HLA typing in extrinsic allergic alveolitis]. Z Erkr Atmungsorgane (1987) 0.75
[Experience in identifying exogenous allergic alveolitis]. Probl Tuberk (1983) 0.75
[Immunologic studies in exogenous allergic alveolitis]. Klin Med (Mosk) (1984) 0.75
[Exogenous allergic alveolitis in tobacco industry workers]. Sov Med (1991) 0.75
[New aspects of chemotherapy of tuberculosis]. Probl Tuberk (1980) 0.75
[An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical]. Probl Tuberk (1990) 0.75
[Objectives of anti-tuberculosis institutions in conducting general dispensarization of the population in the prevention of tuberculosis]. Probl Tuberk (1986) 0.75
[Role of hereditary factors in pulmonary pathology]. Vestn Akad Med Nauk SSSR (1986) 0.75
[Examination of the bronchoalveolar lavage fluid and blood plasma of patients with sarcoidosis]. Klin Med (Mosk) (1987) 0.75
[Immunological status of newly detected patients with destructive pulmonary tuberculosis]. Probl Tuberk (1979) 0.75
[Isolation and study of the morphological properties and immunogenicity of filterable forms of Mycobacterium tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[The effectiveness of measured oxygen therapy in treating pulmonary heart failure in patients with bronchopulmonary diseases]. Klin Med (Mosk) (1990) 0.75
[Side effects of antitubercular agents and current methods of detection of drug allergy in chemotherapy of tuberculosis]. Probl Tuberk (1976) 0.75
[Express method of determining the drug sensitivity of Mycobacterium tuberculosis using a liquid culture medium and a rotating thermostat]. Probl Tuberk (1982) 0.75
[Means of increasing the effectiveness of the modern microbiological diagnosis of tuberculosis and nonspecific lung diseases]. Zh Mikrobiol Epidemiol Immunobiol (1983) 0.75
[Immunological indicators in newly detected pulmonary tuberculosis with different degree of infiltration]. Probl Tuberk (1981) 0.75
[Results and developmental outlook of research in the fields of phthisiology and pulmonology]. Vestn Akad Med Nauk SSSR (1987) 0.75
[Cavern morphology and the dynamics of the bacterial population in different variants of an experimental model of cavernous pulmonary tuberculosis]. Probl Tuberk (1982) 0.75
[A comparative evaluation of the results of classical x-ray study and computed tomography in patients with exogenous allergic alveolitis]. Vestn Rentgenol Radiol (1989) 0.75
[Use of plasmacytapheresis in combined modality therapy of patients with fibrosing alveolitis]. Ter Arkh (1991) 0.75
[Current problems in the diagnosis and treatment of tuberculosis]. Sov Med (1983) 0.75
The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis. Z Erkr Atmungsorgane (1986) 0.75
[Clinical manifestations of extrinsic allergic alveolitis--a disease of tobacco growers]. Klin Med (Mosk) (1989) 0.75
[Vision disorders during the treatment of pulmonary tuberculosis with ethambutol]. Klin Med (Mosk) (1979) 0.75
[Glycolysis components and carbohydrate metabolic enzyme activity of the blood under long-term action of rifampicin and isoniazid]. Biull Eksp Biol Med (1982) 0.75
[The results of bacteriologic research on the bronchoalveolar lavage fluid and blood plasma in patients with sarcoidosis]. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol (1989) 0.75
[The 40th anniversary of the World Health Organization]. Probl Tuberk (1988) 0.75
[Diagnosis and treatment of sarcoidosis]. Sov Med (1990) 0.75
[Diagnostic indicators in exogenous allergic alveolitis (poultry farmers' disease)]. Sov Med (1984) 0.75
[Immunological studies in differential diagnosis of tuberculosis and sarcoidosis]. Klin Med (Mosk) (1977) 0.75
[Collective study of atypical Mycobacteria]. Probl Tuberk (1981) 0.75
[Disseminated lesions of the lungs. Methods of differential diagnosis]. Klin Med (Mosk) (1991) 0.75
[Principal results of the scientific study of the tuberculosis problem of in 1974]. Probl Tuberk (1975) 0.75
[The x-ray morphological characteristics of the early manifestations of sarcoidosis]. Vestn Rentgenol Radiol (1991) 0.75
[The results of treating fibrous-cavernous tuberculosis in patients with different genetic markers]. Ter Arkh (1990) 0.75
[HLA antigens in lung diseases]. Ter Arkh (1985) 0.75
[Clinical value of diagnostic bronchoalveolar lavage in diffuse diseases of the lungs]. Probl Tuberk (1987) 0.75
[Use of lyophilized Löwenstein-Jensen culture medium for determining drug resistance of Mycobacterium tuberculosis]. Lab Delo (1986) 0.75
[Methods in the modern chemotherapy of tuberculosis (a lecture)]. Probl Tuberk (1988) 0.75
[Relation between the dynamics of immunologic indices and newly detected pulmonary tuberculosis patients and the timing of the end of bacterial isolation and the closure of destruction cavities]. Probl Tuberk (1982) 0.75
[Hemosorption and extracorporeal membrane oxygenation of the blood in the therapy of patients with chronic lung diseases]. Probl Tuberk (1986) 0.75
[Current goals of sanatorial treatment of patients with tuberculosis]. Probl Tuberk (1978) 0.75
[Modern problems of phthisiotherapy and the practice of public health]. Klin Med (Mosk) (1985) 0.75
[Differential x-ray diagnosis of disseminated tuberculosis and sarcoidosis of the lungs]. Probl Tuberk (1989) 0.75
[The metabolic correction of erythrocyte function in patients with pulmonary tuberculosis complicated by pulmonary heart failure]. Ter Arkh (1990) 0.75
[Bronchoalveolar lavage in patients with pulmonary tuberculosis]. Probl Tuberk (1984) 0.75
[Current theories on the pathogenesis of tuberculosis (lecture)]. Probl Tuberk (1988) 0.75
[Differential diagnosis of tuberculosis of the respiratory organs]. Probl Tuberk (1979) 0.75
[Activities of the All-Union Scientific Society of Phthisiologists during the period between congresses (1974-1979)]. Probl Tuberk (1979) 0.75
[Differential diagnosis of proctacted pneumonia and recurrent tuberculosis]. Klin Med (Mosk) (1976) 0.75
[Clinical variants of the course and the characteristics of the x-ray changes in extrinsic allergic alveolitis--tobacco growers' disease]. Ter Arkh (1990) 0.75
[Immunological methods of examination in differential diagnosis of various lesions of the middle lobe and lingular segments of the lungs]. Ter Arkh (1978) 0.75
[Principles of rational tuberculosis chemotherapy]. Antibiotiki (1980) 0.75